ErbB2/HER2 governs CDK4 inhibitor sensitivity and timing and irreversibility of G1/S transition by altering c-Myc and cyclin D function
A. N. Ichikawa, K. Murakami, K. Aoki, M. Okada
This study shows how ErbB2 levels affect CDK4 inhibitor sensitivity and the timing of G1/S transition by altering c-Myc and cyclin D function in breast cancer cells.
bioRxiv · May 9, 2024 · PreprintCancer Biology